Table 1 Patient characteristics
From: Feasibility of bedside portable MRI in neonates and children during ECLS
Patient | ECLS device | ECLS cannulation (VV or VA) | ECLS indication | Changes in vital signs | Changes in ECLS flow rate | Time to move the patient into/out of the pMRI (minutes) | MRI time to obtain the images (minutes) | Staff satisfaction (1 = fully satisfied; 5 = not satisfied |
|---|---|---|---|---|---|---|---|---|
1 | Medos Deltastream circuit with a DP3 pump, and a hilite 800 LT oxygenator system, Xenios AG, Aachen, Germany | VV (13 French jugular double lumen cannula; Avalon Elite, Getinge, Rastatt, Germany) | Lung hypoplasia due to multicystic dysplastic kidneys | None | None | 25/15 | 35 | 2 |
2 | Medos Deltastream circuit with a DP3 pump, and a hilite 2400 LT oxygenator system, Xenios AG, Aachen, Germany | VV (14 French jugular and 14 French femoral single lumen cannula; Medtronic, Minneapolis, MN, USA) | ARDS due to Respiratory syncytial virus | None | None | 18/10 | 25 | 1 |
3 | Medos Deltastream circuit with a DP3 pump, and a hilite 7000 LT oxygenator system, Xenios AG, Aachen, Germany | VV (17 French jugular and 17 French femoral single lumen cannula; Medtronic, Minneapolis, MN, USA) | ARDS due to Influenza A | None | None | 12/8 | 18 | 1 |
4 | Medos Deltastream circuit with a DP3 pump, and a hilite 7000 LT oxygenator system, Xenios AG, Aachen, Germany | VA (15 French jugular and 19 French femoral venous and 15 French femoral arterial single lumen cannula; Medtronic, Minneapolis, MN, USA) | Cardiogenic shock due to Parvovirus B19 associated cardiomyopathy | None | None | 15/10 | 22 | 1 |